François B, Garcia Sanchez M, Eggimann P, et al. Suvratoxumab reduces staphylococcus aureus pneumonia in high-risk icu patients: results of the SAATELLITE Study. Am J Resp Crit Care Med. 2019;199:A7358.
Langetermijnresultaten van SABR bij operabel stadium I NSCLC
dec 2021 | Chirurgie, Longoncologie, Radiotherapie